Participants at the HJF Medical Research International in Abuja have been vaccinated in the inaugural Phase 2 clinical trial of a Lassa fever virus (LASV) vaccine candidate.
Musa Adekunle
Advertisement
The News You Need, Delivered To You.
Subscribe to the Guardian today and never miss the stories that shape your Business
Follow Us on Google News
